What the Radiologist Should Know About Treatment of Peritoneal Malignancy.
AJR Am J Roentgenol. 2017 Mar;208(3):531-543. doi: 10.2214/AJR.16.16646. Epub 2017 Jan 11.
Aherne EA1, Fenlon HM1, Shields CJ2, Mulsow JJ2, Cronin CG1.
OBJECTIVE: The purpose of this article is to discuss the role of the radiologist in the treatment of peritoneal cancer, with focus placed on advanced treatment options and selection of patients with resectable disease for whom complete cytoreduction can be achieved.
CONCLUSION: Peritoneal cancers traditionally have been associated with significant morbidity and universal mortality; however, the management of such cancers has evolved substantially. Advanced treatment options, including cytoreductive surgery and intraperitoneal chemotherapy, are associated with significantly improved long-term patient survival. To ensure that patients benefit from aggressive multimodality treatments, the radiologist plays a pivotal role in the multidisciplinary team to ensure careful patient selection, identifying individuals with resectable disease for whom complete cytoreduction can be achieved.